{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:03:47Z","timestamp":1784271827131,"version":"3.55.0"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jdcr.2026.05.011","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:20:25Z","timestamp":1778340025000},"page":"188-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Epidermolysis bullosa acquisita improved with use of dupilumab"],"prefix":"10.1016","volume":"73","author":[{"given":"Eli","family":"Raneses","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin F.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy F.","family":"Schmiedecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Hugh","family":"Lyford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jdcr.2026.05.011_bib1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.abd.2021.09.010","article-title":"Epidermolysis bullosa acquisita","volume":"97","author":"Miyamoto","year":"2022","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jdcr.2026.05.011_bib2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fmed.2018.00362","article-title":"Epidermolysis bullosa acquisita: the 2019 update","volume":"5","author":"Koga","year":"2019","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.jdcr.2026.05.011_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.36849\/JDD.8483","article-title":"Rituximab in the treatment of epidermolysis bullosa acquisita: a systematic review of the literature","volume":"24","author":"Xenopoulou","year":"2025","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2026.05.011_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13023-018-0896-1","article-title":"Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients","volume":"13","author":"Iwata","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jdcr.2026.05.011_bib5","series-title":"Dupilumab","year":"2025"},{"issue":"10","key":"10.1016\/j.jdcr.2026.05.011_bib6","first-page":"1417","article-title":"Treatment of Epidermolysis bullosa acquisita with dupilumab","volume":"22","author":"Diehl","year":"2024","journal-title":"J Dtsch Dermatol Ges"},{"issue":"4","key":"10.1016\/j.jdcr.2026.05.011_bib7","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1111\/1346-8138.17582","article-title":"Treatment of refractory, inflammatory epidermolysis bullosa acquisita with a combination of dupilumab and systemic glucocorticoid","volume":"52","author":"Xing","year":"2025","journal-title":"J Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626002791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626002791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:15:57Z","timestamp":1784268957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512626002791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":7,"alternative-id":["S2352512626002791"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.05.011","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidermolysis bullosa acquisita improved with use of dupilumab","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}